We’re LIIRA CARE
Redefining respiratory self-care
Respiratory self-care technology
LIITA Care is a Copenhagen-based healthcare company developing proprietary technology for respiratory self-care and early respiratory intervention.
The company has developed BREATHOX® from concept through product development, intellectual property, clinical research, regulatory market introduction and commercial use.
BREATHOX® has been commercially available as a CE-marked medical device since 2015.
Latest News
Catch up on the latest news & updates here
Latest News
Catch up on the latest news & updates here
05 September 2022 • Press Release
LIITA Research to be Presented at the ERS Congress 2022
We are proud to announce that our latest scientific discovery was selected by the European Respiratory Society to be presented as Late-Breaking Abstract in the category ‘Best abstracts in COVID-19’ at the forthcoming ERS International Congress in Barcelona.
“We see ERS’ acceptance as an endorsement of our research and the vast treatment potential that the result implies,” says CEO Martin A. Ohrt“ We hope that the publication of our discoveries in the anti-viral field will lead to more collaborations in which we can further uncover the therapeutic potential of the BREATHOX® treatment form”
“Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19“ is presented by Investigation Leader Pr. Suzana Erico Tanni (UNESP, Brazil).
02 September 2022 • Media Update
LIITA Research to be Presented at ERS Congress 2022
We are proud to announce that our latest scientific discovery was selected by the European Respiratory Society to be presented as Late-Breaking Abstract in the category ‘Best abstracts in COVID-19’ at the forthcoming ERS International Congress in Barcelona.
“We see ERS’ acceptance as an endorsement of our research and the vast treatment potential that the result implies,” says CEO Martin A. Ohrt“ We hope that the publication of our discoveries in the anti-viral field will lead to more collaborations in which we can further uncover the therapeutic potential of the BREATHOX® treatment form”
“Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19“ is presented by Investigation Leader Pr. Suzana Erico Tanni (UNESP, Brazil).
Come join us Monday the 5th of September at 12.45 pm (Room 8L).
2022 • News Article
Stay tuned for more news
TBA
Board of Directors
Board member
Henrik Kjær Hansen
Novo Holdings
Board member
Søren Dannelund Reipurth
Lundgrens
Board member
Bjørn Bruun
Investor
Management
CEO & Founder
Martin Ohrt
LIITA Care
Updates
Catch up on the latest news & updates here